EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Combined Value of the Prognostic Nutritional Index and Pan‐Immune‐Inflammation Value in Predicting Neoadjuvant Chemotherapy and Survival in Locally Advanced Colon Cancer: A Retrospective Study

Der kombinierte Wert des Prognostic Nutritional Index und des Pan-Immune-Inflammation Value zur Vorhersage von neoadjuvanter Chemotherapie und Überleben bei lokal fortgeschrittenem Kolonkarzinom: retrospektive Studie

Zihao Chen iD, Jiangyu Li, Ruoxi Gao, Lei Liang, Jun Yang iD, Ting Zhao iD

Immunity, Inflammation and Disease · 2026-11 · 14 (11)

DOI: 10.1002/iid3.70572 ↗

Auf einen Blick

Bei 241 Patient:innen mit lokal fortgeschrittenem Kolonkarzinom war ein höherer PIV-PNI-Score mit schlechterem Ansprechen auf NACT und mit ungünstigeren Überlebensoutcomes verbunden.

Fragestellung

Wie gut sagt ein kombinierter PIV-PNI-Score das Ansprechen auf neoadjuvante Chemotherapie und das Überleben bei LACC voraus?

Methode

Retrospektive Analyse von 241 LACC-Patient:innen nach NACT und radikaler Resektion; TRG nach AJCC/CAP; PIV und PNI vor Behandlung, Cut-offs per ROC.

Ergebnisse

Der PIV-PNI-Score war in der TRG3-Gruppe höher als in der non-TRG3-Gruppe (p < 0,0001). Höherer Score war mit schlechteren Überlebensoutcomes verbunden; multivariat unabhängiger Prognosefaktor für OS und DFS.

Schlussfolgerung der Autor:innen

Der PIV-PNI-Score zeigt laut Autor:innen klinischen Nutzen als Prädiktor für Tumoransprechen auf NACT und Prognose bei LACC.

Kernaussagen

  • Höherer PIV-PNI-Score in der TRG3-Gruppe
  • Höherer Score mit schlechterem OS und DFS verbunden
  • PIV-PNI-Score als unabhängiger Prognosefaktor

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 05.11.2026. Verfasst von Zihao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Neoadjuvant Therapy, Inflammation, Nutrition Assessment. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Teaching Research Project of the First Affiliated Hospital of Kunming Medical University, Health Training Project for High-level Talents in Yunnan, Kunming Medical University Clinical Research Projects.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pan‐immune inflammation value (PIV) and prognostic nutritional index (PNI) are established markers of systemic inflammatory/immune status and nutritional status, respectively. The potential synergistic effect of combining these indices remains unexplored. This study aimed to evaluate the utility of a novel combined PIV‐PNI score for predicting chemosensitivity and survival outcomes in patients with locally advanced colon cancer (LACC) undergoing neoadjuvant chemotherapy (NACT), within a cohort from the Yunnan Plateau region.

Methods

We conducted a retrospective analysis of 241 LACC patients who received NACT followed by radical resection. Tumor response was classified according to AJCC/CAP guidelines, with patients stratified into a TRG3 (minimal or no pathological response) group ( n = 40) and a non‐TRG3 group ( n = 201). Pre‐treatment PIV and PNI were measured, with optimal cut‐off values identified by receiver operating characteristic (ROC) curve analysis. The PIV‐PNI score was calculated as follows: a score of 2 indicated high PIV and low PNI; a score of 1 indicated either high PIV or low PNI alone; and a score of 0 indicated neither.

Results

The PIV‐PNI score was significantly higher in the TRG3 group compared to the non‐TRG3 group ( p < 0.0001). The optimal cut‐off values for PIV and PNI via ROC analysis were ≥ 218.7 and ≤ 50.6, respectively. A higher PIV‐PNI score was associated with inferior survival outcomes. Multivariate analysis identified the PIV‐PNI score as an independent prognostic factor for both overall survival and disease‐free survival.

Conclusions

The PIV‐PNI score, a low‐cost and readily available composite index, demonstrates significant clinical utility as a predictive marker for tumor response to NACT and prognosis in LACC patients. Novelty and Impact of the Work PIV–PNI score, which integrates systemic inflammation and immunonutritional status, demonstrates strong predictive value for chemosensitivity and long‐term survival, offering a clinically accessible tool to guide personalized treatment strategies in the neoadjuvant setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsNeoadjuvant TherapyInflammationNutrition AssessmentHumansRetrospective StudiesPrognosisFemaleMaleMiddle AgedAgedNutritional StatusAdultROC CurveNeoplasm Staging

Stichwörter der Autor:innen

locally advanced colon cancerneoadjuvant chemotherapypan‐immune‐inflammation valueprognosisprognostic nutritional indextreatment response

Autor:innen und Institutionen

  • Department of Surgical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Medical College, Kunming University, Kunming, Yunnan, China.
  • Basic Medical College, Kunming Medical University, Kunming, Yunnan, China.
  • Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

ORCID-Profile: Zihao Chen, Jun Yang, Ting Zhao

Förderung

  • Education Teaching Research Project of the First Affiliated Hospital of Kunming Medical University
  • Health Training Project for High-level Talents in Yunnan
  • Kunming Medical University Clinical Research Projects
  • Kunming Medical University Project for Basic Research in Yunnan
  • National Natural Science Foundation of China
  • Special Project for Basic Research in Yunnan

Zitieren

APA

Chen, Z., Li, J., Gao, R., Liang, L., Yang, J., & Zhao, T. (2026). The Combined Value of the Prognostic Nutritional Index and Pan‐Immune‐Inflammation Value in Predicting Neoadjuvant Chemotherapy and Survival in Locally Advanced Colon Cancer: A Retrospective Study. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70572

Vancouver

Chen Z, Li J, Gao R, Liang L, Yang J, Zhao T. The Combined Value of the Prognostic Nutritional Index and Pan‐Immune‐Inflammation Value in Predicting Neoadjuvant Chemotherapy and Survival in Locally Advanced Colon Cancer: A Retrospective Study. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70572

BibTeX
@article{Chen2026,
  author = {Chen, Zihao and Li, Jiangyu and Gao, Ruoxi and Liang, Lei and Yang, Jun and Zhao, Ting},
  title = {The Combined Value of the Prognostic Nutritional Index and Pan‐Immune‐Inflammation Value in Predicting Neoadjuvant Chemotherapy and Survival in Locally Advanced Colon Cancer: A Retrospective Study},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1002/iid3.70572}
}
Kostenlos starten →